114 related articles for article (PubMed ID: 15019164)
1. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
Lund P; Schubert D; Niketeghad F; Schirmacher P
Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
[TBL] [Abstract][Full Text] [Related]
2. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
3. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
Alexia C; Lasfer M; Groyer A
Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
[TBL] [Abstract][Full Text] [Related]
4. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells.
Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW
Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
Zvibel I; Brill S; Reid LM
J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P
Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387
[TBL] [Abstract][Full Text] [Related]
8. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
[TBL] [Abstract][Full Text] [Related]
9. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?].
Nussbaum T; Vreden S; Farsad M; Schirmacher P; Breuhahn K
Verh Dtsch Ges Pathol; 2005; 89():254-60. PubMed ID: 18035699
[TBL] [Abstract][Full Text] [Related]
12. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
13. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin-like growth factor-binding protein 2 and an IGF-type I receptor-blocking antibody on apoptosis in human teratocarcinoma cells in vitro.
Granerus M; Engström W
Cell Biol Int; 2001; 25(8):825-8. PubMed ID: 11482908
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors.
Nagatomo T; Muta K; Ohga S; Ochiai M; Ohshima K; Hara T
Exp Hematol; 2008 Apr; 36(4):401-11. PubMed ID: 18261839
[TBL] [Abstract][Full Text] [Related]
17. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.
Lamm GM; Christofori G
Cancer Res; 1998 Feb; 58(4):801-7. PubMed ID: 9485038
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II induces apoptosis in osteoblasts.
Gronowicz GA; McCarthy MB; Zhang H; Zhang W
Bone; 2004 Sep; 35(3):621-8. PubMed ID: 15336597
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Breuhahn K; Longerich T; Schirmacher P
Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I.
Fukaya Y; Yamaguchi M
J Cell Biochem; 2005 Sep; 96(1):145-54. PubMed ID: 15880694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]